Role of AMPK throughout meiotic maturation in the mouse oocyte: Evidence for promotion of polar body formation and suppression of premature activation

Molecular Reproduction and Development

Volumn 77, Issue 10, 2010, Pages 888-899

  Downs, Stephen M ^a   Ya, Ru ^a   Davis, Christopher C ^a  

^a Marquette University   (United States)

Author keywords

Activation; AMP activated protein kinase; Meiosis; Oocyte; Polar body

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL EXPERIMENT; ARTICLE; BODY ARMOR; CATALYSIS; CELL ACTIVATION; CELL MATURATION; CHROMATIN; CONTROLLED STUDY; GERMINAL VESICLE; IMMUNOHISTOCHEMISTRY; MALE; MEIOSIS; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL;

AMINOIMIDAZOLE CARBOXAMIDE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANIMALS; CUMULUS CELLS; ENZYME ACTIVATORS; ENZYME INHIBITORS; FEMALE; IMMUNOHISTOCHEMISTRY; MEIOSIS; MICE; MICE, INBRED C57BL; MITOTIC SPINDLE APPARATUS; OOCYTES; PYRAZOLES; PYRIMIDINES; RIBONUCLEOTIDES; TIME FACTORS;

EID: 78649570550     PISSN: 1040452X     EISSN: 10982795     Source Type: Journal    
DOI: 10.1002/mrd.21229     Document Type: Article

References (79)

1. Alexander B, Coppola G, De Berardino D, Rho GJ, St John E, Betts DH, King WA. 2006. The effect of 6-dimethylaminopurine (6-DMAP) and cycloheximide (CHX) on the development and chromosomal complement of sheep parthenogenetic and nuclear transfer embryos. Mol Reprod Dev 73: 20-30.
2. Alexxi DR, Sakamoto K, Bayascas JR. 2006. LKB1-dependent signaling pathways. Ann Rev Biochem 75: 137-163.
3. Baumann P, Mandl-weber S, Emmerich B, Straka C, Schmidmaier R. 2007. Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells. Exp Cell Res 313: 3592-3603.
4. Betterncourt-Dias M, Giet R, Sinka R, Mazumdar A, Lock WG, Balloux F, Zafiropoulos PJ, Yamaguchi S, Winter S, Carthew RW, Cooper M, Jones D, Frenz L, Glover DM. 2004. Genome-wide survey of protein kinases required for cell cycle progression. Nature 432: 980-987.
5. Bilodeau-Goeseels S, Sasseville M, Guillemette C, Richard FJ. 2007. Effects of adenosine monophosphate-activated kinase activators on bovine oocyte nuclear maturation in vitro. Mol Reprod Dev 74: 1021-1034.
6. Carling D. 2004. The AMP-activated protein kinase-A unifying system for energy control. Trends Biochem Sci 29: 18-24.
7. Chen J, Downs SM. 2008. AMP-activated protein kinase is involved in hormone-induced mouse oocyte meiotic maturation in vitro. Dev Biol 313: 47-57.
8. Chen J, Hudson E, Chi MM, Chang AS, Moley KH, Hardie DG, Downs SM. 2006. AMPK regulation of mouse oocyte meiotic resumption in vitro. Dev Biol 291: 227-238.
9. Choi YH, Love LB, Westhusin ME, Hinrichs K. 2004. Activation of equine nuclear transfer oocytes: Methods and timing of treatment in relation to nuclear remodeling. Biol Reprod 70: 46-53.
10. Downs SM. 1990. Stimulation of parthenogenesis in mouse ovarian follicles by inhibitors of monophosphate dehydrogenase. Biol Reprod 43: 427-436.
11. Downs SM. 1995. The influence of glucose, cumulus cells, and metabolic coupling on ATP levels and meiotic control in the isolated mouse oocyte. Dev Biol 167: 502-512.
12. Downs SM, Chen J. 2006. Induction of meiotic maturation in mouse oocytes by adenosine analogs. Mol Reprod Dev 73: 1159-1168.
13. Downs SM, Hudson ED. 2000. Energy substrates and the completion of spontaneous meiotic maturation. Zygote 8: 339-351.
14. Downs SM, Mastropolo AM. 1994. The participation of energy substrates in the control of meiotic maturation in murine oocytes. Dev Biol 162: 154-168.
15. Downs SM, Hudson ER, Hardie DG. 2002a. A potential role for AMP-activated protein kinase in meiotic induction in mouse oocytes. Dev Biol 245: 200-212.
16. Downs SM, Humpherson PG, Leese HJ. 2002b. Pyruvate utilization by mouse oocytes is influenced by meiotic status and the cumulus oophorus. Mol Reprod Dev 62: 113-123.
17. Eppig JJ, Wigglesworth K, Varnum DS, Nadeau JH. 1996. Genetic regulation of traits essential for spontaneous ovarian teratocarcinogenesis in strain LT/Sv mice: Aberrant meiotic cell cycle, oocyte activation, and parthenogenetic development. Cancer Res 56: 5047-5054.
18. Eppig JJ, Wigglesworth K, Hirao Y. 2000. Metaphase I arrest and spontaneous parthenogenetic activation of strain LTXBO oocytes: Chimeric reaggregated ovaries establish primary lesion in oocytes. Dev Biol 224: 60-68.
19. Fan HY, Sun QY. 2004. Involvement of mitogen-activated protein kinase cascade during oocyte maturation and fertilization in mammals. Biol Reprod 70: 535-547.
20. Fan HY, Tong C, Teng C, Lian L, Li SW, Yang ZM, Chen DY, Schatten H, Sun QY. 2003. Characterization of polo-like kinase-1 in rat oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization, and cleavage. Mol Reprod Dev 65: 318-329.
21. Fissore RA, Kurokawa M, Knott J, Zhang M, Smyth J. 2002. Mechanisms underlying oocyte activation and postovulatory ageing. Reproduction 124: 745-754.
22. Fogarty S, Hardie DG. 2009. C-terminal phosphorylation of LKB1 is not required for regulation of AMP-activated protein kinase, BRSK1, BRSK2, or cell cycle arrest. J Biol Chem 284: 77-84.
23. Fujimoto A, Akifusa S, Kamio N, Hirofuji T, Nonaka K, Yamashita Y. 2010. Involvement of mTOR I globular adiponectin-induced generation of reactive oxygen species. Free Radical Res 44: 128-134.
24. Gwinn DM, Shackelford DB, Egan DF, Mihaylova MM, Mery A, Vasquez DS, Turk BE, Shaw RJ. 2008. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30: 214-226.
25. Hardie DG. 2003. Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status. Endocrinology 144: 5179-5183.
26. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Rother S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. 1998. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391: 184-187.
27. Henin N, Vincent MJ, Van den Berghe G. 1996. Stimulation of rat liver AMP-activated protein kinase by AMP analogues. Biochim Biophys Acta 1290: 197-203.
28. Hurley RL, Anderson KA, Franzone JM, Kemp BE, Means AR, Witters LA. 2005. The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066.
29. Igata M, Motoshima H, Tsuruzoe K, Kojima K, Matsumura T, Kondo T, Taguchi T, Nakamaru K, Yano M, Kukidome D, Matsumoto K, Toyonaga T, Asano T, Nishikawa T, Araki I. 2005. Adenosine monophosphate-activated protein kinase suppresses vascular smooth muscle cell proliferation through the inhibition of cell cycle progression. Circ Res 97: 837-844.
30. Imamura K, Ogura T, Kishimoto A, Kaminishi M, Esumi H. 2001. Cell cycle regulation via p53 phosphorlyation by a 5'-AMP activated protein kinase activator, 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, in a human hepatocellular carcinoma cell line. Biochem Biophys Res Commun 287: 562-567.
31. Ishii N, Matsumura T, Knoshita H, Motoshima H, Kojima K, Tsutsumi A, Kawasaki S, Yano M, Senokuchi T, Asano T, Nishikawa T, Araki E. 2009. Activation of AMP-activated protein kinase suppresses oxidized low-density lipoprotein-induced macrophage proliferation. J Biol Chem 284: 34561-34569.
32. Jenne DE, Reimann H, Nezu J-I, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18: 38-43.
33. Jiang JY, Mizuno S, Mizutani E, Sasada H, Sato E. 2002. Parthenogenetic activation and subsequent development of rat oocytes in vitro. Mol Reprod Dev 61: 120-125.
34. Jilek F, Huttelova R, Petr J, Holubova M, Rozinek J. 2001. Activation of pig oocytes using calcium ionophore: Effect of the protein kinase inhibitor 6-dimethyl aminopurine. Reprod Dom Anim 36: 139-145.
35. Jones RG, Plas DR, Kubek S, Buzzai M, Mu J, Xu Y, Birnbaum MJ, Thompson CB. 2005. AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell 18: 283-293.
36. Kaufman MH. 1983. Early mammalian development: Parthenogenetic studies. Cambridge, England: Cambridge University Press.
37. Kaufman HM, Howlett SK. 1986. The ovulation and activation of primary and secondary oocytes in LT/Sv strain mice. Gamete Res 14: 255-264.
38. Kohida H, Rassi JG, Brown CM, Stochaj U. 2007. Localization of AMPK kinase is regulated by stress, cell density and signaling through the MEK ERK1/2 pathway. Am J Physiol Cell Physiol 293: 1427-1436.
39. Kyriakis JM. 2003. At the crossroads: AMP-activated kinase and the LKB1 tumor suppressor link cell proliferation to metabolic regulation. J Biol 2: 26.1-26.4.
40. LaRosa C, Downs SM. 2006. Stress stimulates AMP-activated protein kinase and meiotic resumption in mouse oocytes. Biol Reprod 74: 585-592.
41. LaRosa C, Downs SM. 2007. Meiotic induction by heat stress in mouse oocytes: Involvement of AMP-activated protein kinase and MAPK family members. Biol Reprod 76: 476-486.
42. Leal C, Liu L. 1998. Differential effects of kinase inhibitor and electrical stimulus on activation and histone H1 kinase activity in pig oocytes. Anim Reprod Sci 52: 51-61.
43. Lee JH, Koh H, Kim M, Kim Y, Lee SY, Karess RE, Lee SH, Shong M, Kim JM, Kim J, Chung J. 2007. Energy-dependent regulation of cell structure by AMP-activated protein kinase. Nature 447: 1017-1021.
44. Liu HL, Fan BQ, Wang HH, Cheng YF, Wang GJ. 1997. Effect of 6-methylaminopurine on the resumption of meiosis and parthenogenetic activation in mouse oocytes. Shih Yen Sheng Wu Hsueh Pao J Exp Biol 30: 403-406.
45. Liu L, Ju JC, Yang X. 1998. Parthenogenetic development and protein patterns of newly matured bovine oocytes after chemical activation. Mol Reprod Dev 49: 298-307.
46. Liu CT, Chen CH, Cheng SP, Ju JC. 2002. Parthenogenesis of rabbit oocytes activated by different stimuli. Anim Reprod Sci 70: 267-276.
47. Loi P, Ledda S, Fulka J, Jr., Cappai P, Moor RM. 1998. Development of parthenogenetic and cloned ovine embryos: Effect of activation protocols. Biol Reprod 58: 1177-1187.
48. Ma W, Koch JA, Viveiros MM. 2008. Protein kinase C delta (PKCδ) interacts with microtubule organizing center (MTOC)-associated proteins and participates in meiotic spindle organization. Dev Biol 320: 414-425.
49. Maleszewski M, Yanagimachi R. 1995. Spontaneous and sperm-induced activation of oocytes in Lt/Sv strain mice. Dev Growth Differ 37: 679-685.
50. Mayes MA, Laforest MJ, Guillemette C, Gilchrist RB, Richard FJ. 2007. Adenosine 5'-monophosphate-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes. Biol Reprod 76: 589-597.
51. Miao YL, Liu XY, Qiao TW, Miao DQ, Luo MJ, Tan JH. 2005. Cumulus cells accelerate aging of mouse oocytes. Biol Reprod 73: 1025-1031.
52. Mirouse V, Swick LL, Kazgan N, St Johnston D, Brenman JE. 2007. LKB1 and AMPK maintain epithelial cell polarity under energetic stress. J Cell Biol 177: 387-392.
53. Mitalipov SM, Nusser KD, Wolf DP. 2001. Parthenogenetic activation of rhesus monkey oocytes and reconstructed embryos. Biol Reprod 65: 253-259.
54. Motoshima H, Goldstein BJ, Igata M, Araki E. 2006. AMPK and cell proliferation-AMPK as a therapeutic target for atherosclerosis and cancer. J Physiol 564: 63-71.
55. Nakagawa K, Yamano S, Nakasaka H, Hinokio K, Yoshizawa M, Aono T. 2001. A combination of calcium ionophore and puromycin effectively produces human parthenogenones with one haploid pronucleus. Zygote 9: 83-88.
56. Nakasaka H, Yamano S, Hinokio K, Nakagawa K, Oshizawa M, Aono T. 2000. Effective activation method with A23187 and puromycin to produce haploid parthenogenones from freshly ovulated mouse oocytes. Zygote 8: 203-208.
57. Ongeri EM, Krisher RL. 2001. Glucose and pyruvate metabolism of preimplantation goat blastocysts following in vitro fertilization and parthenogenetic activation. Cloning Stem Cells 3: 115-123.
58. Pahlavan G, Polanski Z, Kalab P, Golsteyn R, Nigg EA, Maro B. 2000. Characterization of polo-like kinase I during meiotic maturation of the mouse oocyte. Dev Biol 220: 392-400.
59. Park M, Song KS, Kim HK, Park YJ, Kim HS, Bae MI, Lee J. 2009. 2-Deoxy-D-glucose protects neural progenitor cells against oxidative stress through the activation of AMP-activated protein kinase. Neurosci Lett 449: 201-206.
60. Pradelli LA, Beneteau M, Chauvin C, Jacquin MA, Marchetti S, Munoz-Pinedo C, Auberger P, Pende M, Ricci JE. 2010. Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 29: 1641-1652.
61. Salt I, Celler JW, Hawley SA, Prescott A, Woods A, Carling D, Hardie DG. 1998. AMP-activated protein kinase: Greater AMP dependence, and preferential nuclear localization, of complexes containing the α2 isoform. Biochem J 334: 177-187.
62. Sano E, Yamamoto Y, Samejima T, Seita Y, Inomata T, Ito J, Kashiwazaki N. 2009. A combined treatment with ethanol and 6-dimethylaminopurine is effective for the activation and further embryonic development of oocytes from Sprague-Dawley and Wistar rats. Zygote 17: 29-36.
63. Shuda K, Schindler K, Ma J, Schultz RM, Donovan PJ. 2009. Aurora kinase B modulates chromosome alignment in mouse oocytes. Mol Reprod Dev 76: 1094-1105.
64. Stricker SA, Swiderek L, Nguyen T. 2010. Stimulators of AMP-activated kinase (AMPK) inhibit seawater- but not cAMP-induced oocyte maturation in a marine worm: Implications for interactions between cAMP and AMPK signaling. Mol Reprod Dev 77: 497-510.
65. Sun SC, Xiong B, Lu SS, Sun QY. 2008. MEK1/2 is a critical regulator of microtubule assembly and spindle organization during rat oocyte meiotic maturation. Mol Reprod Dev 75: 1542-1548.
66. Szczepanska K, Maleszewski M. 2005. LKB1/PAR4 protein is asymmetrically localized in mouse oocytes and associates with meiotic spindle. Gene Expr Pattern 6: 86-93.
67. Szollosi MS, Kubiak JZ, Debey P, de Pennart H, Szollosi D, Maro B. 1993. Inhibition of protein kinases by 6-dimethylaminopurine accelerates the transition to interphase in activated mouse oocytes. J Cell Sci 104: 861-872.
68. Tong C, Fan HY, Lian L, Li SW, Chen DY, Schatten H, Sun QY. 2002. Polo-like kinase-1 is a pivotal regulator of microtubule assembly during mouse oocyte meiotic maturation, fertilization, and early embryonic mitosis. Biol Reprod 67: 546-554.
69. Tong C, Fan HY, Song XF, Schatten H, Sun QY. 2003. Effects of MEK inhibitor U0126 on meiotic progression in mouse oocytes: Microtubule organization, asymmetric division and metaphase II arrest. Cell Res 13: 375-383.
70. Tosca L, Uzbekova S, Chabrolle C, Dupont J. 2007. Possible role of 5'-AMP-activated protein kinase in the metformin-mediated arrest of bovine oocytes at the germinal vesicle stage during in vitro maturation. Biol Reprod 77: 368-378.
71. Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA. 2009. The active form of the metabolic sensor. AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle 8: 1-14.
72. Wani NA. 2008. Chemical activation of in vitro matured dromedary camel (Camelus dromedarious) oocytes: Optimization of protocols. Theriogenology 69: 591-602.
73. Wianny F, Tavares A, Evans M, Glover D, Zernicka-Goetz M. 1998. Mouse polo-like kinase associates with acentriolar spindle poles, meiotic chromosomes and spindle midzone during oocyte maturation. Chromosoma 107: 430-439.
74. Winger QA, De La Fuente R, King WA, Armstrong DT, Watson AJ. 1997. Bovine parthenogenesis is characterized by abnormal chromosomal complements: Implications for maternal and paternal co-dependence during early bovine development. Dev Gen 21: 160-166.
75. Yao LJ, Sun QY. 2005. Characterization of aurora-a in porcine oocytes and early embryos implies its functional roles in the regulation of meiotic maturation, fertilization and cleavage. Zygote 13: 23-30.
76. Yin XJ, Lee HS, Jeon JT, Kong IK. 2007. Effect of culture medium and prostaglandin I(2) (PGI(2)) analogue on in vitro development of parthenogenetically activated cat oocytes. J Reprod Dev 53: 1053-1058.
77. Zang Y, Yu LF, Nan FJ, Feng LY, Li J. 2009. AMP-activated protein kinase is involved in neural stem cell growth suppression and cell cycle arrest by 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and glucose deprivation by down-regulating phospho-retinoblastoma protein and cyclin D. J Biol Chem 284: 6175-6184.
78. Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, Wu M, Ventre J, Doebber T, Fujii N, Musi N, Hirshman MF, Goodyear LJ, Moller DE. 2001. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108: 1167-1174.
79. Zhu Z, Jiang W, McGinley JN, Thompson HJ. 2005. 2-Deoxyglucose as an energy restriction mimetic agent: Effects on mammary carcinogenesis and on mammary tumor cell growth in vitro. Cancer Res 65: 7023-7030.